glp-1 autoinjector Amneal Resubmits DHE NDA and Receives FDA Approval of Exenatide, a Generic Injectable Agonist | American Pharmaceutical Review Injectable GLP-1s Thrive as Oral

The GLP-1 or glucagon-like peptide-1 receptor agonists are also widely recognized for treating type 2 diabetes mellitus alongside obesity, as they mimic natural hormones, boosting insulin, lowering glucagon, slowing gastric emptying, and increasing satiety

Feasibility of tracheal reconstruction using silicone-stented aortic allografts

Additionally, a study found that in SCI animal models, the IncGm36569/miRNA-5627-5p/FSP1 axis was inhibited through molecular sponge action, thereby targeting this axis to inhibit neuronal ferroptosis (Shao et al., 2022)

CMS has used similar tools in the past to test premium stabilization, drug vouchers, and reduced cost sharing for generics without changing statutory coverage rules

, , , pH -1